Ryan A. Murr is a distinguished Partner at Gibson Dunn, where he co-chairs the Life Sciences Practice Group and serves as co-partner-in-charge of the San Francisco office. With over 25 years of experience, Ryan is a leading corporate lawyer in the life sciences industry, specializing in mergers and acquisitions, capital markets, and royalty finance. He has led over 300 transactions totaling more than $65 billion, including high-profile deals like the $6 billion acquisition of Ortho Clinical Diagnostics by Quidel. Recognized for his innovative approach, Ryan is ranked Band 1 by Chambers USA and has been nominated multiple times as Corporate Attorney of the Year by LMG Life Sciences. His expertise extends to advising on corporate governance and SEC reporting for both public and private companies.
LinkedIn
